CVS Health Launches Company To Produce Cheaper Versions Of Expensive Biotech Drugs - Forbes
forbes.comSubmitted by forbes3707 in business
CVS Health is launching a new company, Cordavis, to commercialize and produce biosimilar drugs, the cheaper versions of expensive prescriptions derived from biotechnology.